The Future of Drug Transport

Modern science has allowed today's researchers to bring a greater number of drug candidates into development than ever before - with the impact of drug transporters being the most recent cutting edge technology. Millions in investment dollars and critical research time are lost if a compound fails during development, and development failures are often the result of ADMET challenges.

The team at Qualyst is dedicated to delivering more efficient and effective drug transporter technologies to the life sciences sector every year, providing better knowledge for faster and more accurate results.

Qualyst continually seeks out and develops novel technologies within the drug transport area. Our goal is to bring novel products to the marketplace each year, leveraging our platform B-CLEAR technology. Qualyst pursues an aggressive in-licensing strategy for technologies amenable to development into medium- and high-throughput screens, or cell-based technologies that add new insight into the drug transport area, including in cell systems other than hepatocytes. To submit a technology for consideration, please email a non-confidential summary and any published patent applications (US or PCT) to marcsedam [AT] qualyst [DOT] com.